Antithymocyte Globulin
Showing 1 - 25 of 632
MDS Trial in Seoul (cyclophosphamide, fludarabine, and antithymocyte globulin)
Active, not recruiting
- Myelodysplastic Syndromes
- cyclophosphamide, fludarabine, and antithymocyte globulin
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023
Diabetes, Type 1 Trial (Antithymocyte Globulin, Placebo (for ATG))
Recruiting
- Diabetes Mellitus, Type 1
- Antithymocyte Globulin
- Placebo (for ATG)
-
Gainesville, FloridaUniversity of Florida
Jan 5, 2023
Haploidentical Hematopoietic Stem Cell Transplantation Trial in Seoul (ATG-LDPTCy)
Recruiting
- Haploidentical Hematopoietic Stem Cell Transplantation
-
Seoul, Korea, Republic ofSamsung Medical Center
Sep 11, 2023
Graves Orbitopathy Trial in Katowice (rabbit anti-thymocyte globulin)
Recruiting
- Graves Orbitopathy
- rabbit anti-thymocyte globulin
-
Katowice, Silesia, PolandDepartment of Internal Medicine and Oncological Chemotherapy, Me
Jan 14, 2022
Severe Aplastic Anemia Trial run by the NHLBI (Cohort 1: hATG, CsA, EPAG Day 14 to Month 6, Cohort 2: hATG, CsA, EPAG Day 14 to
Recruiting
- Severe Aplastic Anemia
- Cohort 1: hATG, CsA, EPAG Day 14 to Month 6
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 5, 2022
Haploidentical Hematopoietic Stem Cell Transplantation Trial in Beijing (Individual Antithymocyte globulin, Antithymocyte
Recruiting
- Haploidentical Hematopoietic Stem Cell Transplantation
- Individual Antithymocyte globulin
- Antithymocyte globulin
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Jan 15, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in Boston (Antithymocyte Globulin,
Active, not recruiting
- Acute Myeloid Leukemia
- +6 more
- Antithymocyte Globulin
- Clofarabine
-
Boston, Massachusetts
- +1 more
Jan 25, 2022
Fanconi Anemia Trial in Minneapolis (biological, drug, procedure)
Completed
- Fanconi Anemia
- Anti-Thymocyte Globulin
- +7 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Oct 8, 2021
Renal Transplantation Trial (TCD601, belatacept, ATG)
Not yet recruiting
- Renal Transplantation
- TCD601
- +5 more
- (no location specified)
Dec 20, 2022
Haploidentical Hematopoietic Stem Cell Transplantation Trial in Beijing (Antithymocyte Globulin)
Recruiting
- Haploidentical Hematopoietic Stem Cell Transplantation
- Antithymocyte Globulin
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Dec 12, 2021
Aplastic Anemia Trial in Worldwide (rabbit antithymocyte globulin)
Completed
- Aplastic Anemia
- rabbit antithymocyte globulin
-
Creteil, France
- +13 more
Sep 21, 2021
Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia Trial in Duarte (biological, procedure, drug, other)
Not yet recruiting
- Recurrent Severe Aplastic Anemia
- Refractory Severe Aplastic Anemia
- Anti-Thymocyte Globulin
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 23, 2023
Acute Graft Rejection, Diabetes Trial in Vancouver (Tacrolimus)
Completed
- Acute Graft Rejection
- Diabetes
-
Vancouver, British Columbia, CanadaSt. Paul's Hospital
Nov 4, 2022
Severe Aplastic Anemia (SAA) Trial (Romiplostim, Antithymocyte Globulin, Cyclosporine A)
Not yet recruiting
- Severe Aplastic Anemia (SAA)
- Romiplostim
- +2 more
- (no location specified)
Sep 2, 2022
Hematologic Malignancies Trial in New York (Busulfan 3.2 mg/kg/day, Fludarabine, Melphalan)
Recruiting
- Hematologic Malignancies
- Busulfan 3.2 mg/kg/day
- +5 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Mar 14, 2022
Myeloid Diseases Trial in Middletown, New York (drug, radiation, procedure)
Recruiting
- Myeloid Diseases
- Antithymocyte globulin (Rabbit)
- +5 more
-
Middletown, New Jersey
- +1 more
Jan 19, 2023
Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Stanford (anti-thymocyte globulin, cyclosporine, Lymphoid
Active, not recruiting
- Mycoses
- +5 more
- anti-thymocyte globulin
- +2 more
-
Stanford, CaliforniaStanford University School of Medicine
Jun 16, 2022
Cutaneous T-cell Lymphoma, T-Prolymphocytic Leukemia, T-Large Granulocytic Leukemia Trial in Columbus (Romidepsin, Busulfan,
Recruiting
- Cutaneous T-cell Lymphoma
- +4 more
- Romidepsin
- +4 more
-
Columbus, OhioThe Ohio State University Cancer Center
Apr 18, 2022
Kidney Transplant, Type 1 Diabetes Trial in Boston (Alpha 1-Antitrypsin, Islet Transplantation, Thymoglobulin)
Active, not recruiting
- Kidney Transplant
- Type 1 Diabetes
- Alpha 1-Antitrypsin
- +4 more
-
Boston, MassachusettsMassachusetts General Hospital
Nov 15, 2021
Aplastic Anemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Houston (Anti-Thymocyte Globulin,
Recruiting
- Aplastic Anemia
- +3 more
- Anti-Thymocyte Globulin
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Dec 1, 2021
Non-Malignant Tumor Trial in Seattle (biological, drug, radiation, procedure)
Recruiting
- Non-Malignant Neoplasm
- Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 29, 2022
Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor, CNS Germ Cell Tumor Trial in Houston (drug, procedure, biological)
Recruiting
- Anaplastic Ependymoma
- +14 more
- Etoposide
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Aug 17, 2022
Aplastic Anemia Trial run by the NHLBI (Campath-1H, r-ATG, CsA)
Completed
- Aplastic Anemia
- Campath-1H
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 2, 2021
Renal Failure Trial in Columbus (Everolimus, Sirolimus)
Completed
- Renal Failure
-
Columbus, OhioThe Ohio State University Wexner Medical Center
Nov 2, 2021
Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune Trial in Denver, Seattle (biological,
Recruiting
- Autoimmune Disease
- +18 more
- Anti-Thymocyte Globulin
- +9 more
-
Denver, Colorado
- +2 more
Feb 1, 2023